Blueprint Medicines Corporation (BPMC) Social Stream



Blueprint Medicines Corporation (BPMC): $102.39

0.32 (-0.31%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add BPMC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#113 of 358

in industry

BLUEPRINT MEDICINES CORP (BPMC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BLUEPRINT MEDICINES CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $136 $84 $113.222 $82.97 36.46%
2021-11-10 9 $136 $84 $114.444 $82.97 37.93%
2021-11-19 9 $136 $84 $115.777 $82.97 39.54%
2021-11-29 9 $139 $84 $115.888 $82.97 39.67%
2022-01-12 9 $135 $84 $113.333 $82.97 36.6%
2022-01-25 9 $135 $84 $110.555 $82.97 33.25%
2022-01-31 9 $135 $84 $108.444 $82.97 30.7%
2022-02-08 9 $135 $84 $104.777 $82.97 26.28%
2022-02-17 9 $133 $82 $100.625 $82.97 21.28%
2022-03-01 10 $133 $71 $97.333 $82.97 17.31%
2022-04-12 10 $133 $71 $97.888 $82.97 17.98%
2022-04-28 10 $133 $68 $97.555 $82.97 17.58%
2022-05-04 10 $133 $68 $96.7 $82.97 16.55%
2022-05-18 10 $152 $65 $100.272 $82.97 20.85%
2022-06-01 10 $152 $65 $99.363 $82.97 19.76%
2022-06-10 10 $152 $41 $96.909 $82.97 16.8%
2022-06-14 10 $152 $41 $92.454 $82.97 11.43%
2022-07-27 12 $152 $40 $86.461 $82.97 4.21%
2022-08-02 10 $152 $40 $86.461 $82.97 4.21%
2022-08-03 13 $152 $40 $86.23 $82.97 3.93%
2022-08-17 13 $152 $40 $88.214 $82.97 6.32%
2022-08-18 13 $152 $40 $87.285 $82.97 5.2%
2022-08-22 13 $152 $40 $87.714 $82.97 5.72%
2022-09-06 13 $152 $40 $88.428 $82.97 6.58%
2022-10-10 14 $152 $40 $89.533 $82.97 7.91%
2022-10-26 14 $152 $40 $89.8 $82.97 8.23%
2022-11-02 15 $152 $40 $85.133 $82.97 2.61%
2022-11-04 16 $115 $40 $78.733 $82.97 -5.11%
2022-12-12 16 $115 $40 $78.4 $82.97 -5.51%
2022-12-14 17 $115 $40 $77.25 $82.97 -6.89%
2022-12-20 17 $115 $40 $77.437 $82.97 -6.67%
2023-01-23 17 $115 $41 $76.937 $82.97 -7.27%
2023-02-06 17 $115 $41 $75.375 $82.97 -9.15%
2023-02-10 17 $115 $41 $75.062 $82.97 -9.53%
2023-02-14 17 $115 $41 $74.625 $82.97 -10.06%
2023-02-17 17 $114 $41 $69.812 $82.97 -15.86%
2023-02-23 17 $114 $41 $69.875 $82.97 -15.78%
2023-02-27 17 $114 $38 $69.25 $82.97 -16.54%
2023-02-28 17 $114 $38 $69.25 $82.97 -16.54%
2023-03-28 17 $114 $38 $69.5 $82.97 -16.23%
2023-04-25 17 $114 $38 $69.5 $82.97 -16.23%
2023-05-05 17 $114 $41 $70.2 $82.97 -15.39%
2023-05-23 18 $114 $41 $71.562 $82.97 -13.75%
2023-05-24 18 $114 $41 $72.437 $82.97 -12.69%
2023-06-07 18 $114 $41 $72.125 $82.97 -13.07%
2023-06-14 17 $114 $43 $74.666 $82.97 -10.01%
2023-07-24 17 $114 $42 $74.6 $82.97 -10.09%
2023-07-26 17 $114 $42 $74.866 $82.97 -9.77%
2023-08-02 17 $114 $42 $75.133 $82.97 -9.45%
2023-08-17 17 $114 $40 $75 $82.97 -9.61%
2023-08-21 17 $114 $40 $75.066 $82.97 -9.53%
2023-10-25 17 $114 $40 $74.4 $82.97 -10.33%
2023-10-26 17 $114 $40 $75.266 $82.97 -9.29%
2023-10-27 17 $114 $50 $77.25 $82.97 -6.89%
2023-10-28 17 $114 $50 $77.562 $82.97 -6.52%
2023-12-11 17 $114 $50 $76.125 $82.97 -8.25%
2023-12-12 17 $114 $50 $77.375 $82.97 -6.74%
2023-12-19 17 $115 $50 $80.812 $82.97 -2.6%
2023-12-22 18 $115 $50 $81.941 $82.97 -1.24%

The Trend in the Analyst Price Target


Over the past 43 months, BPMC's average price target has gone down $8.13.

Over the past 48 weeks, BPMC's average upside potential has been 37.79%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-06 17 115 41 75.375 45.67 65.04%
2023-03-21 17 114 38 69.500 45.52 52.68%
2023-03-30 17 114 38 69.500 44.29 56.92%
2023-06-07 17 114 43 74.200 60.03 23.6%
2023-12-11 17 114 50 76.647 80.99 -5.36%

BPMC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.83 12 1 3 2 2 18

The Trend in the Broker Recommendations


BPMC's average broker recommendation rating improved by 0.29 over the prior 16 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how BLUEPRINT MEDICINES CORP fares relative to all US stocks, note that its variance in analysts' estimates is lower than -5681.3% of that group.
  • BLUEPRINT MEDICINES CORP's number of analysts covering the stock is higher than 6111.78% of stocks in the mid market cap category.
  • BPMC has a higher upside potential (average analyst target price relative to current price) than 1031.46% of Pharmaceutical Products stocks.
  • BPMC has a higher average analyst price target than 5759.08% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BLUEPRINT MEDICINES CORP are QURE, XNCR, and PAHC.

Is BPMC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!